Genalyte Raises $36M in Funding

Nov 21, 2016

|

NEW YORK (GenomeWeb) – Genalyte said today that it has raised an additional $36 million in a financing round led by investors Khosla Ventures and Redmile Group.

San Diego-based Genalyte will use the funds to further refine its Maverick Detection System, a photonic microring sensor-based platform that the company is developing for rapid blood testing in outpatient settings like doctors' offices.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

On to Supercomputing

New US Department of Commerce rules will affect supercomputing in China, according to the Wall Street Journal.

More Than a Century Away

A new analysis finds that it will be more than a century until female computer scientists publish at the same rate as their male counterparts, ScienceInsider reports.

From the "Cell's View"

Broad Institute researchers describe an approach they've dubbed "DNA microscopy."

PLOS Studies Explore Host Responses to Viral Infection, Febrile Illness Culprits

In PLOS this week: epigenetic changes following hepatitis C virus treatment, metagenomic analysis of Ugandan children with febrile illness, and more.

Featured White Papers

BlueBee Data Security & Compliance

Epigenomic Analysis of Sorted Retinal Ganglion Cells using ATAC-seq

Type 1 Interferon Gene Expression Analysis: Precision Medicine in Lupus

Jun

25

Featured Webinar

Error-Corrected Sequencing to Detect Measurable Residual Disease in Post-Transplant MDS Cases

Jul

23

Featured Webinar

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients.

Jul

24

Featured Webinar

Comparison of Group B Streptococcus Molecular Assays for Routine Screening in Pregnant Women

This webinar will share the results of comparisons of commercially available nucleic acid amplification tests for use in routine screening of pregnant women for Group B Streptococcus (GBS).

Jul

25

Featured Webinar

Cell-free DNA Testing for Fetal Aneuploidy: Lessons Learned and Implications for Clinical Practice

This webinar will discuss the evolution of fetal aneuploidy screening and the most recent evidence around the implementation of prenatal cell-free DNA testing in clinical practice.

Menu